Animas and LifeScan, members of the Johnson & Johnson (J&J) Family of Diabetes Companies, have collaborated to co-develop OneTouch Ping Glucose Management System.
OneTouch Ping Glucose Management System is an insulin pump that wirelessly communicates with a blood glucose meter-remote.
The pump includes many capabilities and with the OneTouch Ping meter-remote, a person can check blood glucose levels, calculate insulin doses, and opt to wirelessly instruct the pump to deliver insulin without touching the pump at all.
LifeScan has received FDA 510(k) clearance of its OneTouch Verio Meter and Test Strip platform, paving the way for a new portfolio of self-monitoring of blood glucose (SMBG) products in the US.
Animas is partnering with DexCom to develop a continuous glucose monitoring (CGM)-enabled insulin pump and CGM system, which integrates a DexCom CGM sensor with an Animas insulin pump.
Animas also formed a partnership with the Juvenile Diabetes Research Foundation in January 2010 to develop an artificial pancreas, an automated system to dispense insulin to patients based on changes in glucose levels